Skip to main content
Log in

Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The most frequent extra-intestinal manifestation in ulcerative colitis (UC) around the world is joint involvement. There are no previous data in Latin America that is about this aspect of disease; hence, the aim of this study was to determine the frequency and factors associated to joint involvement in Mexican patients with UC. A total of 295 patients with histological diagnosis of UC were studied, divided into two groups: (1) 154 cases with at least one joint affection (arthralgia, peripheral, or axial arthropathy (sacroilitis (SI) or ankylosing spondylitis (AS))) and (2) 141 controls that had never presented any joint involvement during the clinical course of UC. Demographic, clinical, and laboratory variables were collected from the clinical records, at the time of presentation of the joint involvement for the cases and with the last information available for controls. A total of 52.2% of the patients had joint involvement, which was also the most frequent extra-intestinal manifestation (EIM). The frequency of peripheral arthralgia was 46.8% and of axial arthropathy was 5.4% (2.7% AS, 2.4% SI, and 0.3% both). The female gender (P = 0.01, OR = 3.061 95% CI: 1.311–7.15), elevated erythrocyte sedimentation rate (ESR) (P = 0.07, OR = 8.04 95% CI: 1.759–36.764), and moderate disease activity by Truelove and Witts criteria (P = 0.024, OR = 4.37 95% CI: 1.211–15.78) were factors associated at the time of presentation of the joint affection. Joint involvement is the most frequent EIM in Mexican patients with UC. The female gender, elevated ESR, and disease activity are factors associated with its presentation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Abraham C, Cho JH (2009) Inflammatory bowel disease. N Engl J Med 361:2066–2078

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Rodríguez-Leal GA (2001) Enfermedad Inflamatoria: Epidemiología y Patogénesis. Médica Sur 8:84–89

    Google Scholar 

  3. Yamamoto-Furusho JK (2009) Clinical epidemiology of ulcerative colitis in Mexico: a single hospital-based study in a 20-year period (1987-2006). J Clin Gastroenterol 43:221–224

    Article  PubMed  Google Scholar 

  4. Bywaters EG, Ansell BM (1958) Arthritis associated with ulcerative colitis: a clinical and pathological study. Ann Rheum Dis 17:169–183

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Atzeni F, Defendenti C, Ditto MC et al (2014) Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev 13:20–23

    Article  PubMed  Google Scholar 

  6. Pérez-Alamino R, Maldonado-Ficco H, Maldonado-Cocco JA (2016) Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol 35:291–296

    Article  PubMed  Google Scholar 

  7. Assche GV, Dignass A, Bokemeyer B et al (2013) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 7:1–33

    Article  PubMed  Google Scholar 

  8. Danese S, Semeraro S, Papa A et al (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11:7227–7236

    Article  PubMed  PubMed Central  Google Scholar 

  9. Barreiro M, Dominguez JE, Nuñez MC et al (2007) Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol 19:73–78

    Article  Google Scholar 

  10. Palm O, Bernklev T, Moum B, Gran JT (2005) Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J Rheumatol 32:1755–1759

    PubMed  Google Scholar 

  11. Al-Jarallah K, Shehab D, Al-Azmi W, Al-Fadli A (2013) Rheumatic complications of inflammatory bowel diseaseamong Arabs: a hospital-based study in Kuwait. Int J Rheum Dis 16:134–138

    Article  PubMed  Google Scholar 

  12. Salvarani C, Vlachonnikolis I, Van Der Heijde DM et al (2001) Mucoskeletal manifestations in a population based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 36:1307–1313

    Article  CAS  PubMed  Google Scholar 

  13. Bourikas LA, Papadakis KA (2009) Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis 15:1915–1924

    Article  PubMed  Google Scholar 

  14. Leclerc-Jacob S, Lux G, Rat AC et al (2014) The prevalence of inflammatory sacroiliitis assessed on magnetic resonance imaging of inflammatory bowel disease: a retrospective study performed on 186 patients. Aliment Pharmacol Ther 39:957–962

    Article  CAS  PubMed  Google Scholar 

  15. Van Der Heijde D, Sieper J, Maksymowych WP et al (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis 70:905–908

    Article  PubMed  Google Scholar 

  16. Denmark VK, Mayer L (2013) Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update. Expert Rev Clin Immunol 9:77–92

    Article  CAS  PubMed  Google Scholar 

  17. Atzeni F, Benucci M, Sallì S, Bongiovanni S et al (2013) Different effects of biological drugs in rheumatoid arthritis. Autoimmun Rev 12:575–579

    Article  CAS  PubMed  Google Scholar 

  18. Atzeni F, Talotta R, Benucci M et al (2013) Immunogenicity and autoimmunity during anti-TNF therapy. Autoimmun Rev 12:703–708

    Article  CAS  PubMed  Google Scholar 

  19. Olivieri I, D'angelo S, Padula A et al (2013) Can we reduce the dosage of biologics in spondyloarthritis? Autoimmun Rev 12:691–693

    Article  CAS  PubMed  Google Scholar 

  20. Roberts H, Rai SN, Pan J et al (2014) Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion 90:122–129

    Article  CAS  PubMed  Google Scholar 

  21. Yuksel I, Ataseven H, Basar O et al (2011) Peripheral arthritis in the course of inflammatory bowel diseases. Dig Dis Sci 56:183–187

    Article  PubMed  Google Scholar 

  22. Alharbi OR, Azzam NA, Almalki AS et al (2014) Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol 20:17525–17531

    Article  PubMed  PubMed Central  Google Scholar 

  23. Zippi M, Corrado C, Pica R et al (2014) Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 20:17463–17467

    Article  PubMed  PubMed Central  Google Scholar 

  24. Christodoloulou DK, Katsanos KH, Kitsanou M et al (2002) Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature. Dig Liver Dis 34:781–786

    Article  Google Scholar 

  25. Arvikar SL, Fisher MC (2011) Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med 4:123–131

    Article  PubMed  PubMed Central  Google Scholar 

  26. Orchard TR, Wordsworth BP, Jewell DP (1998) Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42:387–391

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Dorofeyev AE, Vasilenko IV, Rassokhina OA (2009) Joint extraintestinal manifestations in ulcerative colitis. Dig Dis 27:502–510

    Article  CAS  PubMed  Google Scholar 

  28. De Vos M (2009) Joint involvement associated with inflammatory bowel disease. Dig Dis 27:511–515

    Article  PubMed  Google Scholar 

  29. Holden W, Orchard T, Wordsworth P (2003) Enteropathic arthritis. Rheum Dis 29:513–530

    Google Scholar 

  30. Balbir-Gurman A, Schapira D, Nahir M (2001) Arthritis related to ileal pouchitis following total proctocolectomy for UC. Semin Arthritis Rheum 30:242–248

    Article  CAS  PubMed  Google Scholar 

  31. Abi Karam G, Awada H (2003) Ileal pouchitis and arthritis. Semin Arthritis Rheum 33:215

    Article  PubMed  Google Scholar 

  32. Elia PP, Fogaça HS, Barros RG (2007) Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the “Clementino Fraga Filho” University Hospital, Rio de Janeiro, RJ, Brazil. Arq Gastroenterol 44:332–339

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jesús K. Yamamoto-Furusho.

Ethics declarations

This work was performed according to the principles expressed in the Declaration of Helsinki. The study was approved by the local ethical committee and a written informed consent was obtained from all patients.

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamamoto-Furusho, J.K., Sarmiento-Aguilar, A. Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study. Clin Rheumatol 37, 677–682 (2018). https://doi.org/10.1007/s10067-017-3834-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3834-z

Keywords

Navigation